Enhancing Representativeness in Cardiovascular Clinical Trials

This chapter highlights the crucial role of industry in ensuring diverse representation in clinical trials for cardiovascular disease. It outlines best practices for enhancing inclusiveness and emphasizes the positive outcomes associated with community engagement and transparent data reporting.